Our Approach
We focus on the development of multifunctional modality platforms that enable simultaneous stimulation of multiple steps in the cancer immune cycle (Fig. 1). We are actively forming strategic alliances with world-leading research institutes and companies in the immuno-oncology field and have successfully built a robust and competitive pipeline (Fig. 2). We are also strengthening collaboration within Astellas to jointly address next generation immuno-oncology therapeutics based on our deep understanding of the tumor microenvironment.
Please click here to learn more about Astellas’ Primary Focus in Immuno-Oncology.
Fig.1 Cancer Immunity Cycle and Our Programs
Fig.2 Immuno-Oncology Pipeline
